{"id":"NCT02577406","sponsor":"Celgene","briefTitle":"An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation","officialTitle":"A Phase 3, Multicenter, Open-label, Randomized Study Comparing the Efficacy and Safety of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Late Stage Acute Myeloid Leukemia Harboring an Isocitrate Dehydrogenase 2 Mutation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12-30","primaryCompletion":"2020-03-17","completion":"2024-03-25","firstPosted":"2015-10-16","resultsPosted":"2022-09-10","lastUpdate":"2025-05-18"},"enrollment":319,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Leukemia, Myeloid","Isocitrate Dehydrogenase"],"interventions":[{"type":"DRUG","name":"AG-221","otherNames":[]},{"type":"OTHER","name":"BSC","otherNames":[]},{"type":"DRUG","name":"Azacitidine","otherNames":[]},{"type":"DRUG","name":"Low-dose cytarabine (LDAC)","otherNames":[]},{"type":"DRUG","name":"Intermediate-dose cytarabine (IDAC)","otherNames":[]}],"arms":[{"label":"AG-221 plus Best supportive care (BSC)","type":"EXPERIMENTAL"},{"label":"Conventional care regimen (CCR)","type":"ACTIVE_COMPARATOR"}],"summary":"This is an international, multicenter, open-label, randomized, Phase 3 study comparing the efficacy and safety of AG-221 versus conventional care regimens (CCRs) in subjects 60 years or older with acute myeloid leukemia (AML) refractory to or relapsed after second- or third-line AML therapy and positive for an isocitrate dehydrogenase (IDH2) mutation.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From randomization to death due to any cause (up to approximately 49 months)","effectByArm":[{"arm":"AG-221","deltaMin":6.5,"sd":null},{"arm":"Conventional Care Regimens (CCRs)","deltaMin":6.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.2288"}]},"eligibility":{"minAge":"60 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":93,"countries":["United States","Australia","Austria","Belgium","Brazil","Canada","China","Czechia","Denmark","France","Germany","Italy","Russia","South Korea","Spain","Taiwan","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["38507688"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","https://www.BMSClinicalTrials.com"]},"adverseEventsSummary":{"seriousAny":{"events":139,"n":157},"commonTop":["NAUSEA","DIARRHOEA","THROMBOCYTOPENIA","HYPOKALAEMIA","DECREASED APPETITE"]}}